Drug
Conserved Therapy
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
2
33%
Ph phase_2
4
67%
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
4(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Other(6)
Detailed Status
unknown5
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (33.3%)
Phase 24 (66.7%)
Trials by Status
suspended117%
unknown583%
Recent Activity
0 active trials
Showing 5 of 6
suspendedphase_1
Mesenchymal Stem Cells Treat Liver Cirrhosis
NCT01233102
unknownphase_2
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
NCT00993941
unknownphase_1
Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
NCT01224327
unknownphase_2
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
NCT01223664
unknownphase_2
Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure
NCT01221454
Clinical Trials (6)
Showing 6 of 6 trials
NCT01233102Phase 1
Mesenchymal Stem Cells Treat Liver Cirrhosis
NCT00993941Phase 2
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
NCT01224327Phase 1
Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
NCT01223664Phase 2
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
NCT01221454Phase 2
Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure
NCT00976287Phase 2
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6